Stay updated on Dapagliflozin and Autonomic Function in T2D Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.

Latest updates to the Dapagliflozin and Autonomic Function in T2D Clinical Trial page
- Check5 days agoChange DetectedThe page’s 403 Forbidden response was replaced by a “TypeError: Failed to fetch” message. The NIH transition announcement was removed, and the displayed site revision changed from v3.7.2 to v3.8.0.SummaryDifference2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA sitewide NIH notice about terminology changes under Executive Order 14434 appears, and the site revision changed from v3.7.1 to v3.7.2. The study page continues to show a 403 Forbidden error.SummaryDifference1%

- Check40 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study record content with a generic notice rather than updating the study information.SummaryDifference19%

- Check61 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0, indicating a new version of the ClinicalTrials.gov page. This change is administrative and does not modify the study data or displayed information.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This represents a metadata/backend update to the page rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin and Autonomic Function in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.